Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from HitIQ Limited ( (AU:HIQ) ) is now available.
HitIQ Limited has disclosed a significant change in director Matthew Clayworth’s interests, following the conversion of convertible notes into fully paid ordinary shares held through Harmil Angel Investments Pty Ltd. The transaction, approved at an extraordinary general meeting in February 2026, resulted in the issuance of 123,388,031 new shares at a deemed price of $0.011712 per share, increasing Harmil Angel Investments’ holding to 284,516,635 shares.
Clayworth’s direct and superannuation-linked holdings in HitIQ remain unchanged, while the substantial increase in his indirect stake consolidates his economic interest and influence in the company. The conversion reduces outstanding convertible debt and strengthens HitIQ’s equity base, potentially improving balance sheet flexibility and aligning the director’s incentives more closely with the long-term performance of the sports technology business.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HitIQ Limited is an Australian-listed company operating in the sports technology and health data sector, providing equipment and analytics solutions aimed at monitoring and managing athlete head impacts and related brain health. The company targets professional and amateur sports markets seeking enhanced player welfare, performance insights, and concussion management tools.
Average Trading Volume: 496,955
Technical Sentiment Signal: Sell
Current Market Cap: A$8.23M
For a thorough assessment of HIQ stock, go to TipRanks’ Stock Analysis page.